Knight Therapeutics (TSE:GUD) Trading Up 2% – Still a Buy?

Shares of Knight Therapeutics Inc. (TSE:GUDGet Free Report) were up 2% on Monday . The stock traded as high as C$9.70 and last traded at C$9.66. 55,797 shares traded hands during mid-day trading, a decline of 42% from the average daily volume of 96,049 shares. The stock had previously closed at C$9.47.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group set a C$9.50 price target on Knight Therapeutics and gave the company a “buy” rating in a research report on Friday, May 8th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of C$9.50.

Get Our Latest Report on GUD

Knight Therapeutics Stock Down 0.2%

The firm has a market capitalization of C$946.96 million, a price-to-earnings ratio of 64.27, a P/E/G ratio of -1,013.50 and a beta of -0.19. The firm has a fifty day moving average price of C$9.69 and a 200 day moving average price of C$8.31. The company has a current ratio of 2.28, a quick ratio of 1.79 and a debt-to-equity ratio of 4.29.

Knight Therapeutics (TSE:GUDGet Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported C($0.03) earnings per share (EPS) for the quarter. The business had revenue of C$143.97 million during the quarter. Knight Therapeutics had a net margin of 2.72% and a return on equity of 1.91%. Sell-side analysts anticipate that Knight Therapeutics Inc. will post 0.1009486 EPS for the current fiscal year.

Knight Therapeutics Company Profile

(Get Free Report)

Knight Therapeutics Inc, headquartered in Montreal, Canada, is a pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America. Knight’s Latin American subsidiaries operate under United Medical, Biotoscana Farma and Laboratorio LKM. Knight Therapeutics Inc’s shares trade on the TSX under the symbol GUD. For more information about Knight Therapeutics Inc, please visit the company’s web site at www.knighttx.com or www.sedarplus.ca.

Recommended Stories

Receive News & Ratings for Knight Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Knight Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.